CRIS Current Research Information System

RECANATINI, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.889
AS - Asia 7.799
EU - Europa 6.405
AF - Africa 458
SA - Sud America 422
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 19
Totale 24.013
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.782
SG - Singapore 2.113
CN - Cina 2.078
VN - Vietnam 1.923
GB - Regno Unito 1.554
IT - Italia 1.294
DE - Germania 822
HK - Hong Kong 529
SE - Svezia 520
UA - Ucraina 508
FR - Francia 438
IN - India 407
RU - Federazione Russa 333
BR - Brasile 310
IE - Irlanda 220
JP - Giappone 155
CI - Costa d'Avorio 138
NL - Olanda 121
ZA - Sudafrica 115
KR - Corea 112
EE - Estonia 102
TG - Togo 96
FI - Finlandia 80
JO - Giordania 79
ES - Italia 77
CH - Svizzera 65
CA - Canada 58
PH - Filippine 56
AR - Argentina 50
BG - Bulgaria 46
HR - Croazia 46
PK - Pakistan 45
SC - Seychelles 40
BD - Bangladesh 38
ID - Indonesia 37
TH - Thailandia 35
BE - Belgio 31
NG - Nigeria 31
TR - Turchia 31
IQ - Iraq 29
TW - Taiwan 29
MX - Messico 28
PL - Polonia 28
CZ - Repubblica Ceca 27
IR - Iran 24
AT - Austria 22
SA - Arabia Saudita 19
AU - Australia 18
EU - Europa 16
EC - Ecuador 15
MY - Malesia 14
LT - Lituania 13
CL - Cile 12
GR - Grecia 12
MT - Malta 11
VE - Venezuela 11
CO - Colombia 10
RO - Romania 10
EG - Egitto 9
UZ - Uzbekistan 9
LB - Libano 8
PT - Portogallo 8
BZ - Belize 7
MA - Marocco 7
AE - Emirati Arabi Uniti 5
IL - Israele 5
NP - Nepal 5
PE - Perù 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
ET - Etiopia 3
LV - Lettonia 3
MD - Moldavia 3
PY - Paraguay 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
CR - Costa Rica 2
DZ - Algeria 2
GT - Guatemala 2
KE - Kenya 2
KH - Cambogia 2
LK - Sri Lanka 2
MZ - Mozambico 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CU - Cuba 1
CY - Cipro 1
GD - Grenada 1
HU - Ungheria 1
JM - Giamaica 1
Totale 23.997
Salva come PNG Salva come JPEG
Città #
Singapore 1.411
Southend 1.332
Fairfield 868
Ashburn 800
Chandler 556
Santa Clara 524
Hong Kong 494
San Jose 453
Ho Chi Minh City 421
Seattle 417
Hanoi 412
Wilmington 410
Woodbridge 402
Houston 359
Jacksonville 340
Ann Arbor 338
Cambridge 326
Princeton 290
Hefei 283
Bologna 277
Beijing 262
Dong Ket 228
Dublin 220
Boardman 208
Lauterbourg 154
Nanjing 146
Abidjan 137
Tokyo 136
Westminster 132
Padova 131
Los Angeles 114
Berlin 105
Lomé 96
Milan 85
Seoul 85
New York 82
Amman 78
Buffalo 75
Jinan 72
Saint Petersburg 64
Helsinki 63
Da Nang 58
Shenyang 57
Hebei 54
Dallas 53
Mülheim 52
Haiphong 50
Guangzhou 46
Shanghai 46
Frankfurt am Main 45
Munich 45
Sofia 44
Medford 40
Redondo Beach 39
San Diego 39
Council Bluffs 38
Mahé 38
São Paulo 38
Changsha 37
Nanchang 37
Bern 36
Redmond 34
Verona 34
Dearborn 33
Zhengzhou 33
Tianjin 31
Abeokuta 30
Barcelona 30
Chicago 29
Hangzhou 28
Brussels 27
Orem 27
Bengaluru 26
Turin 24
Phoenix 22
Norwalk 21
Olalla 21
Quận Bình Thạnh 21
Des Moines 19
Hải Dương 19
Modena 19
Bangkok 18
Haikou 18
Jakarta 18
Ningbo 18
Rome 18
The Dalles 18
Warsaw 18
Biên Hòa 17
Falkenstein 17
Leawood 17
Yubileyny 17
Baghdad 16
Can Tho 16
Florence 16
Harbin 16
Jiaxing 15
Johannesburg 15
London 15
Madrid 15
Totale 15.124
Salva come PNG Salva come JPEG
Nome #
A small molecule targeting the multifactorial nature of Alzheimer's disease 516
La metadinamica nello studio dell'energia libera di complessi recettoriali binari 275
Characterisation of bioactive compounds in wine by-products: toward the valorisation of sustainable resources 274
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation 256
An automated docking protocol for HERG channel blockers. 256
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. 251
Structure-Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo-Irreversible Inhibitors Related to Xanthostigmine 247
Dynamic Docking: A Paradigm Shift in Computational Drug Discovery 236
Computational design and discovery of "minimally structured" hERG blockers. 235
Acetylcholinesterase inhibitors as starting point towards improved Alzheimer’s disease therapeutics 226
A molecular dynamics study of reovirus attachment protein sigma1 reveals conformational changes in sigma1 structure 222
Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells 222
Protein Tunnels: The Case of Urease Accessory Proteins 219
LDH inhibition impacts on heat shock response and induces senescence of hepatocellular carcinoma cells 216
Computational drug discovery under RNA times 213
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. 203
SINTESI PARALLELA DI UNA COLLEZIONE DI PICCOLE MOLECOLE SIMIL-NATURALI MEDIANTE REAZIONE DOMINO KNOEVENAGEL/ DIELS-ALDER 201
Progettazione e sintesi di derivati poliamminici per il trattamento della malattia di Alzheimer 200
Antiproliferative agents that interfere with the cell cycle at the G(1)-->S transition: further development and characterization of a small library of stilbene-derived compounds 200
SAR and binding mode at the h-AChE active site of pseudo-irreversible inhibitors related to Xanthostigmine 200
Computational approaches to the study of dual-site and peripheral site binding ache inhibitors 199
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. 198
Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives. 197
AClAP, Autonomous hierarchical agglomerative Cluster Analysis based protocol to partition conformational datasets 194
Binding Residence Time through Scaled Molecular Dynamics: A Prospective Application to hDAAO Inhibitors 194
Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A 192
A comparative study on the application of hierarchical-agglomerative clustering approaches to organize outputs of reiterated docking runs. 191
Collecting and assessing human lactate dehydrogenase-A conformations for structure-based virtual screening 188
CHOLINESTERASE INHIBITORS: SAR AND ENZYME INHIBITORY ACTIVITY OF 3-[omega-(BENZYLMETHYLAMINO)ALKOXY]XANTHEN-9-ONES 186
Domino Knovenaegel/Diels-Alder Sequence Coupled to Suzuki Reaction: a Powerful Synthetic Platform for Chemical Biology 185
Targeting the Protein Tunnels of the Urease Accessory Complex: A Theoretical Investigation 184
Density Functional Studies on the Nazarov Reaction Involving Cyclic Systems. 183
Alpha7 nicotinic acetylcholine receptor agonists: prediction of their binding affinity through a molecular mechanics Poisson-Boltzmann surface area approach 182
Role of phosphorylated Thr160 for the activation of the CDK2/Cyclin A complex 181
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cells 181
Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach 180
Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of diphenidol: novel M4 muscarinic receptor antagonists 179
Mapping cholesterol interaction sites on serotonin transporter through coarse-grained molecular dynamics 178
Domino Knoevenagel/Diels–Alder sequence coupled to Suzuki reaction: a valuable synthetic platform for chemical biology 177
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity. 176
Targeting the JAK/STAT Pathway: A Combined Ligand- And Target-Based Approach 176
Density functional study of the enzymatic reaction catalyzed by a cyclin-dependent kinase 174
A Computational Study of the Binding of Propidium to the Peripheral Anionic Site of Human Acetylcholinesterase 174
Target-related applications of first principles quantum chemical methods in drug design 173
Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme 171
Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer's Disease 171
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells. 170
Predicting Residence Time and Drug Unbinding Pathway through Scaled Molecular Dynamics 168
Derivati a struttura benzofenonica come inibitori dell'acetilcolinesterasi 167
Exploring Conformational Dynamics of the Extracellular Venus flytrap Domain of the GABAB Receptor: A Path-Metadynamics Study 167
In silico modelling--pharmacophores and hERG channel models 166
Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5 164
Targeting Alzheimer’s disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238 164
Exploring complex protein-ligand recognition mechanisms with coarse metadynamics 163
An Integrated Markov State Model and Path Metadynamics Approach to Characterize Drug Binding Processes 162
Synthesis and conformational preferences of cyclic unnatural di- and tri-peptides containing L-Valine unit. Part 2 161
Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease 161
An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington's disease and multiple sclerosis 160
Imidazolylmethylbenzophenones as highly potent aromatase inhibitors. 160
Multi-target-directed coumarin derivatives: hAChE and BAC1 inhibitors as potential anti-Alzheimer compounds 158
PREPARATION AND STEREOCHEMICAL CHARACTERIZATION OF ENANTIOMERIC HOMOISOFLAVONES ACTIVE AS AROMATASE INHIBITORS 157
Computational study of the phosphoryl transfer catalyzed by a cyclin-dependent kinase 157
Characterization of Cholinesterase inhibitors by means of immobilized enzyme reactor 154
Network modeling helps to tackle the complexity of drug-disease systems 152
Memoquin: a new therapeutic poly-agent for Alzheimer's disease 151
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective 150
The role of the peripheral anionic site and cation-pi interactions in the ligand penetration of the human AChE gorge. 149
Memoquin: a new compound to attack Alzheimer's disease drug discovery 148
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases 147
Cyclin-dependent kinases: bridging their structure and function through computations 147
Heterocyclic inhibitors of AChE acylation and peripheral sites. 147
Preparation of 2,5-bis-diamine-[1,4]benzoquinone derivatives for the treatment of Alzheimer's disease and a process for their preparation and intermediates thereof. 145
Design, Synthesis, and Biological and Crystallographic Evaluation of Novel Inhibitors ofPlasmodium falciparumEnoyl-ACP-reductase (PfFabI) 145
Probing the transport of Ni(II) ions through the internal tunnels of the Helicobacter pylori UreDFG multimeric protein complex 145
Identification of a Terphenyl-Based Small Molecule That Induces Differentiation in Leukemia Cells 144
QT prolongation through hERG K(+) channel blockade: Current knowledge and strategies for the early prediction during drug development 144
Structure-Activity Relationships of Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone. 4. Futher Investigation on the Inner Spacer. 142
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System 141
Sequential Virtual Screening Approach to the Identification of Small Organic Molecules as Potential BACE-1 Inhibitors 141
Conformational plasticity of kinases: molecular dynamics simulation of the conformational changes in the activation loop and the PSSARLE helix of Cdk5 140
The role of Li(+), Na(+), and K(+) in the ligand binding inside the human acetylcholinesterase gorge 140
Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243) 139
MEMOQUIN: A MULTIPOTENT ACETYLCHOLINESTERASE INHIBITOR WITH EXCELLENT IN VIVO ACTIVITY 138
Applicazione dell'analisi statistica a studi di docking e virtual screening condotti su Cdk2 138
The role of fragment-based and computational methods in polypharmacology. 137
Predicting reactivity and stereoselectivity in the Nazarov reaction: A combined computational and experimental study 136
null 136
Modeling the hERG potassium channel in a phospholipid bilayer: Molecular dynamics and drug docking studies 136
Modeling hERG and its interactions with drugs: recent advances in light of current potassium channel simulations 135
Structure-Activity Relationships of New Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone 134
In silico antitarget screening 134
How dynamic docking simulations can help to tackle tough drug targets 134
Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors 134
Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation 133
QSAR and pharmacophores for drugs involved in hERG blockage 132
Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists. 131
Single-molecule pulling simulations can discern active from inactive enzyme inhibitors 131
Effect of new ubiquinone-imidazo[2,1-b] thiazoles on mitochondrial Complex I (NADH ubiquinone reductase) and on mitochondrial permeability transition pore. 131
Development of a multisite model for Ni(II) ion in solution from thermodynamic and kinetic data 131
Protein Dynamics of the HIF-2α PAS-B Domain upon Heterodimerization and Ligand Binding 130
Totale 17.559
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.722
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021663 0 0 0 0 0 0 0 0 0 0 136 527
2021/20222.427 266 54 186 179 223 157 71 201 102 150 401 437
2022/20232.830 272 422 165 323 178 190 75 193 517 109 211 175
2023/2024952 53 147 68 102 74 154 45 79 30 89 54 57
2024/20253.460 110 576 342 211 776 188 220 128 50 168 115 576
2025/20267.144 758 770 716 602 825 477 699 275 1.249 564 209 0
Totale 24.450